There is overwhelming evidence that genetic factors play a role in the
predisposition to suffer the development of the chronic inflammatory
bowel diseases. The genetic analysis of complex diseases, such as ulce
rative colitis and Crohn's disease, is difficult. The presence of dise
ase heterogeneity, the relative low frequency in the population, the d
egree to which first-degree relatives are affected (approximately 10%)
, the presence of genes with minor genetic effects, and ethnic differe
nces are some of the difficulties encountered when identifying disease
susceptibility loci. Two major approaches to identifying these genes
are being followed at present. The first, family-based, consists of st
udying linkage analysis in sibling pairs and parental transmission in
genome-nide screening using microsatellite markers. These studies are
appropriate and helpful for finding genes of major or moderate effects
but may provide difficulty when identifying genes with minor effects.
Risch and Merikangas have pointed to the power of association studies
utilizing candidate genes in families. These studies should be consid
ered in the future in genome-wide screens when technologic advances pe
rmit. The second approach is based on classic epidemiologic designs, p
opulation-based studies, using candidate genes in the framework of a b
iologic hypothesis. Recent data using both approaches in both Crohn's
disease and ulcerative colitis are reviewed. The results of genome-wid
e linkage studies have not reached consensus but suggest that these di
seases are different and polygenic in nature. We have started our stud
ies with the hypothesis that an abnormal immune dysbalance contributes
to the biologic basis of disease. We therefore study polymorphisms in
genes encoding proinflammatory and regulatory cytokines. Preliminary
data of these association studies suggest the importance of several ge
nes with small effects in determining the severity and prognosis of th
ese diseases.